about
Sodium arsenite delays the differentiation of C2C12 mouse myoblast cells and alters methylation patterns on the transcription factor myogeninInorganic Arsenic-induced cellular transformation is coupled with genome wide changes in chromatin structure, transcriptome and splicing patternsExposure to moderate arsenic concentrations increases atherosclerosis in ApoE-/- mouse modelPeripheral Arterial Disease and Its Association With Arsenic Exposure and Metabolism in the Strong Heart StudyArsenic exposure perturbs epithelial-mesenchymal cell transition and gene expression in a collagen gel assayDose-responsive gene expression changes in juvenile and adult mummichogs (Fundulus heteroclitus) after arsenic exposureInfluence of arsenate and arsenite on signal transduction pathways: an updateImpact of environmental chemicals on lung development.Arsenic induces sustained impairment of skeletal muscle and muscle progenitor cell ultrastructure and bioenergetics.Arsenic and lung disease mortality in Bangladeshi adults.Arsenic toxicology: translating between experimental models and human pathology.Chronic low-level arsenite exposure through drinking water increases blood pressure and promotes concentric left ventricular hypertrophy in female mice.Arsenic Promotes NF-Κb-Mediated Fibroblast Dysfunction and Matrix Remodeling to Impair Muscle Stem Cell Function.Cardiovascular effects of arsenic: clinical and epidemiological findings.Sodium arsenite represses the expression of myogenin in C2C12 mouse myoblast cells through histone modifications and altered expression of Ezh2, Glp, and Igf-1.Health effects and arsenic species in urine of copper smelter workers.Molecular Docking Assessment of Efficacy of Different Clinically Used Arsenic Chelator Drugs
P2860
Q28385528-4B23FB91-DD05-447B-9786-A06E3584A8CFQ28390396-BE7420C7-0514-41B3-94AA-785980DD6539Q28390580-F3419E56-B6B3-4F2A-BAB1-8E9AB0A9C639Q28396309-881F82A3-989F-4186-8ACE-16A72F8F4CAFQ30494905-A43CEF0E-C4FC-41BD-979F-7446084AD09BQ33976810-7A5DB54A-41F2-433C-827D-DFB13B18AA9AQ34024633-12A14F70-D23C-4BFE-9117-00EFF7612666Q34060063-74150F81-069B-4D98-8F00-D89F20784406Q34158099-5A02E79B-EC8C-4710-820A-95452CFB3462Q35089506-F72819C9-4C07-46A9-B6C0-5B88A48A44ADQ35591935-3683D8D4-9A81-44DB-987D-DD1FF6CC45DAQ36672606-9F6CC990-E3A9-4A89-9EA4-C6800BF7E879Q36756954-96C43056-EC1C-4DD0-8E97-F76C7F9768D9Q38135772-8E241809-53A1-4BAD-B1FA-DEF16C55E64FQ39378020-321123E7-5B82-4BD4-A2D0-E5E38C55BEF9Q42706204-2C6EDD99-59A9-413E-B726-10A7C231C2FCQ58919655-B7744C29-6AF9-4FED-949E-6F8E151E0E3E
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Arsenic-induced decreases in the vascular matrix.
@en
type
label
Arsenic-induced decreases in the vascular matrix.
@en
prefLabel
Arsenic-induced decreases in the vascular matrix.
@en
P2093
P2860
P356
P1476
Arsenic-induced decreases in the vascular matrix
@en
P2093
Allison M Hays
Angeline S Andrew
James J Sollome
Joshua W Hamilton
Laurel S Rodgers
Richard R Vaillancourt
Todd D Camenisch
P2860
P304
P356
10.1177/0192623308323919
P407
P577
2008-09-23T00:00:00Z